SEP 9, 2026 · JOURNAL ARTICLE
The high price of innovation: addressing financial toxicity and healthcare inequity in gynecological malignancies
Frontiers in Oncology
A narrative review synthesizing evidence on financial toxicity in gynecological oncology and policy recommendations for equitable access to innovation, grounded in published literature but without new empirical data.
Reported
Financial toxicity prevalence in…up to 50%
Overall objective financial toxic…56.96%